Cargando…

Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial–Mesenchymal Transition

SIMPLE SUMMARY: Tumor budding (TB) is an emerging prognostic marker in various cancers; specifically, its role is well established in colorectal cancer. There are very few studies on TB’s role in gynecological cancers. Thus, we studied tumor budding relationships with gynecological cancers and tried...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ailia, Muhammad Joan, Thakur, Nishant, Chong, Yosep, Yim, Kwangil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946491/ https://www.ncbi.nlm.nih.gov/pubmed/35326582 http://dx.doi.org/10.3390/cancers14061431

Ejemplares similares

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis
por: Thakur, Nishant, et al.
Publicado: (2022)

Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape
por: Ailia, Muhammad Joan, et al.
Publicado: (2022)

High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis
por: Thakur, Nishant, et al.
Publicado: (2021)

Recent Application of Artificial Intelligence in Non-Gynecological Cancer Cytopathology: A Systematic Review
por: Thakur, Nishant, et al.
Publicado: (2022)

Recent Applications of Artificial Intelligence from Histopathologic Image-Based Prediction of Microsatellite Instability in Solid Cancers: A Systematic Review
por: Alam, Mohammad Rizwan, et al.
Publicado: (2022)

High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal Transition
por: Thakur, Nishant, et al.
Publicado: (2021)

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
por: Chong, Yosep, et al.
Publicado: (2020)

Calculated Tumor-Associated Neutrophils Are Associated with the Tumor—Stroma Ratio and Predict a Poor Prognosis in Advanced Gastric Cancer
por: Kim, Eun Young, et al.
Publicado: (2022)

Intratumoral Budding in Pretreatment Biopsies, among Tumor Microenvironmental Components, Can Predict Prognosis and Neoadjuvant Therapy Response in Colorectal Adenocarcinoma
por: Yim, Kwangil, et al.
Publicado: (2022)

Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis: A Multicenter Study
por: Chong, Yosep, et al.
Publicado: (2021)

Tumour budding and poorly differentiated clusters in colon cancer – different manifestations of partial epithelial–mesenchymal transition
por: Pavlič, Ana, et al.
Publicado: (2022)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review
por: Ailia, Muhammad Joan, et al.
Publicado: (2022)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

The Role of Cytokines in Epithelial–Mesenchymal Transition in Gynaecological Cancers: A Systematic Review
por: Ray, Irene, et al.
Publicado: (2023)

Modified Tumor Budding as a Better Predictor of Lymph Node Metastasis in Early Gastric Cancer: Possible Real-World Applications
por: Yim, Kwangil, et al.
Publicado: (2021)

The Role of Neuropilin-2 in the Epithelial to Mesenchymal Transition of Colorectal Cancer: A Systematic Review
por: Lungulescu, Cristina, et al.
Publicado: (2022)

Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
por: Orrapin, Santhasiri, et al.
Publicado: (2022)

Current Trends of Artificial Intelligence for Colorectal Cancer Pathology Image Analysis: A Systematic Review
por: Thakur, Nishant, et al.
Publicado: (2020)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer
por: Okuyama, Kohei, et al.
Publicado: (2023)

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition
por: Li, Pin-Dong, et al.
Publicado: (2018)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Uterine Cervical Angioleiomyoma Mimicking Squamous Cell Carcinoma
por: Lee, Jiwon, et al.
Publicado: (2023)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer
por: Yu, Wei, et al.
Publicado: (2018)

Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer
por: Karamitopoulou, Eva
Publicado: (2013)

Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
por: Zheng, Shaoqiu, et al.
Publicado: (2022)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Pectasides, Eirini, et al.
Publicado: (2014)

FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)

A Systematic Review of Mesenchymal Epithelial Transition Factor (MET) and Its Impact in the Development and Treatment of Non-Small-Cell Lung Cancer
por: Bodén, Embla, et al.
Publicado: (2023)

Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition
por: Xu, Rong, et al.
Publicado: (2019)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival
por: Kucia-Tran, Justyna A, et al.
Publicado: (2016)

SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients
por: Nfonsam, Landry E, et al.
Publicado: (2019)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

Hematologic markers of distant metastases and poor prognosis in gynecological cancers
por: Abu-Shawer, O., et al.
Publicado: (2019)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g955asjuacaies42u2ogcrsmsp